Literature DB >> 16898029

A descriptive clinical evaluation of arthroscopic synovectomy in rheumatoid knees: a prospective study.

Sharath K Rao1, Sripathi Rao, A Monappa Naik.   

Abstract

OBJECTIVE: To evaluate the clinical outcome of arthroscopic synovectomy for persistent rheumatoid synovitis of the knee joints.
DESIGN: Prospective clinical study.
SETTING: Kasturba Medical College Hospital, Manipal. PATIENTS: Fifty two knee joints in 46 patients. MEASUREMENTS: The effect of the procedure and its influence in the progression of the disease process on knee joints were assessed in terms of reduction of pain, improvement in range of motion, improvement in functional activity and recurrence of synovitis with effusion.
RESULTS: During the average follow up period of 5 years, the patients showed appreciable improvement (90% of knee joints) until 3 years of follow up. At the end of 5 years of follow up, it reduced to about 75%.
CONCLUSIONS: Arthroscopic synovectomy along with medical treatment can control the disease process and preserve the knee joint function for up to 3 years.

Entities:  

Mesh:

Year:  2006        PMID: 16898029     DOI: 10.4038/cmj.v51i1.1368

Source DB:  PubMed          Journal:  Ceylon Med J        ISSN: 0009-0875


  3 in total

Review 1.  Rheumatoid synovectomy: does the surgical approach matter?

Authors:  Peter N Chalmers; Seth L Sherman; Bradley S Raphael; Edwin P Su
Journal:  Clin Orthop Relat Res       Date:  2011-01-07       Impact factor: 4.176

2.  Treatment for chronic synovitis of knee: arthroscopic or open synovectomy.

Authors:  Xiaoyun Pan; Xianlong Zhang; Zhongtang Liu; Hong Wen; Xin Mao
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

3.  Arthroscopic synovectomy of the knee joint for rheumatoid arthritis.

Authors:  Marina Lipina; Maxim Makarov; Victor Mukhanov; Alexander Karpashevich; Sergey Maglevaniy; Vera Amirdjапоvа; Sergey Archipov
Journal:  Int Orthop       Date:  2018-10-03       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.